Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

🇮🇳 The Hindu (IN) —
Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

AI Summary

Bharat Biotech arm Nucelion and VeGen Bio will partner on VL-2511, a CAR-T therapy candidate for multiple myeloma. Nucelion will provide technology transfer and clinical- and commercial-stage manufacturing.

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

Deals Health CAR-T therapy multiple myeloma VL-2511 Bharat Biotech Nucelion VeGen Bio biopharmaceutical partnership

Read original source →